// App-Quantinova.ai

603 : Integrating Genetic Risk Factors with Age, Presenting White Cell Count and MRD Response As Continuous Variables to Predict Relapse in Paediatric Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Anthony V. Moorman

Principal Investigators

  • Amir Enshaei

  • David -Connor

  • Jack Bartram

  • Jeremy Hancock

  • Christine Harrison

  • Sujith Samarasinghe

  • John Moppett

  • Ajay J. Vora

  • Nicholas Goulden

Medical Centers

  • Northern Institute for Cancer Research Newcastle University, Newcastle, United Kingdom

  • Department of Pediatric Anesthesiology, Great Ormond Street Hospital,NHS, London, United Kingdom

  • Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom

  • Department of Paediatric Haematology, Sheffield Childrens Hospital, Sheffield, United Kingdom

  • Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim